Publication date: Jul 09, 2026
The team then screened the vectors in mice whose brains had been transplanted with human glial progenitor cells. The team also needed a better way to distribute those vectors throughout the brain. To do so, they turned to the glymphatic system, a network of fluid-filled pathways that circulates cerebrospinal fluid through the brain to clear metabolic waste. Each contained small changes to its outer protein shell, or capsid, which determines the types of cells a virus can infect. This study shows that by combining targeted vector engineering with glymphatic delivery, we can begin to build that future.
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | disease progression |
| disease | MESH | infection |
| drug | DRUGBANK | Tropicamide |
| disease | MESH | lysosomal storage diseases |
| disease | MESH | neurodegenerative disorders |
| disease | MESH | Huntington’s disease |
| disease | MESH | neurological disorders |
| disease | MESH | multiple sclerosis |
Original Article
(Visited 71 times, 1 visits today)